Touro University Nevada (Touro) is Nevada’s largest school of medicine, the state’s only school of osteopathic medicine, fully accredited, and a private, non-profit, Jewish-sponsored institution. Opened in 2004, Touro was established to help address critical needs in health care and education and as a resource for community service throughout the state. Touro is now home to nearly 1,500 students, in a wide variety of degree programs including osteopathic medicine, physician assistant studies, education, nursing, occupational therapy, physical therapy, and medical health sciences. The university’s Henderson campus includes a multi-specialty health center and a multi-disciplinary Center for Autism and Developmental Disabilities.
The Nevada campus is part of Touro College and University System in New York, an international system of Jewish-sponsored, non-profit institutions of higher and professional education. Touro University Nevada is accredited by the WASC Senior College & University System (WSCUS) as a branch campus of Touro University California and licensed in Nevada by the Commission on Post-Secondary Education. Additionally, each academic program maintains full accreditation with its discipline’s governing agency.
Touro University Nevada does not discriminate on the basis of race, ethnicity, age, sex, gender, color, creed, national origin, religion, sexual orientation or disability.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2004
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Touro University Nevada founded?
Touro University Nevada was founded in 2004.
What industry is Touro University Nevada in?
Touro University Nevada operates in Higher Education. Find similar Higher Education investors on gritt.io.
Where is Touro University Nevada based?
Touro University Nevada is headquartered in Henderson, United States.
Find investors for your startup like Touro University Nevada
Gritt sends AI-personalised outreach to each investor — from your Gmail
